Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Copolov

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
The Medical Journal of Australia|March 4, 1998
MJA practice essentials. 8. Psychoses: a primary care perspectiveD L Copolov
Australian and New Zealand Journal of Medicine|February 1, 1985
Opioid biology: the next set of questionsD L Copolov
Platelets|November 4, 2010
Phorbol esters increase [(3)h]-dopamine uptake by human plateletsB Dean, D L Copolov
Life Sciences|January 1, 1992
An assay to measure the simultaneous uptake of [3H]dopamine and [14C]serotonin by the human platelet reveals an imipramine-insensitive [3H]dopamine uptake mechanismB Dean, D L Copolov
Life Sciences|January 1, 1989
Dopamine uptake by platelets is selective, temperature dependent and not influenced by the dopamine-D1 or dopamine-D2 receptorB Dean, D L Copolov
European Journal of Pharmacology|December 7, 1989
Dopamine uptake by the human platelet: effects of dopamine receptor agonistsB Dean, D L Copolov
The Medical Journal of Australia|July 21, 2000
Schizophrenia todayD L Copolov, B S Singh
Drugs|December 1, 1983
Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implicationsD L Copolov, R D Helme
The Journal of Pharmacy and Pharmacology|January 1, 1991
Inhibition of [3H]dopamine uptake by platelets by the dopamine-D2 receptor agonist RU 24926B Dean, P Srikanthan, D L Copolov
Psychiatry Research|June 1, 1996
Typical and atypical neuroleptic drugs decrease platelet 3H-dopamine uptake in the ratS Sundram, B Dean, D L Copolov
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
The Medical Journal of Australia|March 4, 1998
MJA practice essentials. 8. Psychoses: a primary care perspectiveD L Copolov
Australian and New Zealand Journal of Medicine|February 1, 1985
Opioid biology: the next set of questionsD L Copolov
Platelets|November 4, 2010
Phorbol esters increase [(3)h]-dopamine uptake by human plateletsB Dean, D L Copolov
Life Sciences|January 1, 1992
An assay to measure the simultaneous uptake of [3H]dopamine and [14C]serotonin by the human platelet reveals an imipramine-insensitive [3H]dopamine uptake mechanismB Dean, D L Copolov
Life Sciences|January 1, 1989
Dopamine uptake by platelets is selective, temperature dependent and not influenced by the dopamine-D1 or dopamine-D2 receptorB Dean, D L Copolov
European Journal of Pharmacology|December 7, 1989
Dopamine uptake by the human platelet: effects of dopamine receptor agonistsB Dean, D L Copolov
The Medical Journal of Australia|July 21, 2000
Schizophrenia todayD L Copolov, B S Singh
Drugs|December 1, 1983
Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implicationsD L Copolov, R D Helme
The Journal of Pharmacy and Pharmacology|January 1, 1991
Inhibition of [3H]dopamine uptake by platelets by the dopamine-D2 receptor agonist RU 24926B Dean, P Srikanthan, D L Copolov
Psychiatry Research|June 1, 1996
Typical and atypical neuroleptic drugs decrease platelet 3H-dopamine uptake in the ratS Sundram, B Dean, D L Copolov
Pageof 10